Literature DB >> 32300021

IL-6 in pulmonary hypertension: why novel is not always best.

Mark Toshner1,2, Alex Rothman3,4.   

Abstract

Entities:  

Year:  2020        PMID： 32300021     DOI： 10.1183/13993003.00314-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  6 in total

1.  Targeting Inflammation in Pulmonary Artery Hypertension: Is It Time to Forget About the Lungs?

Authors:  Douglas L Mann
Journal:  Circ Heart Fail       Date:  2021-12-20       Impact factor: 8.790

2.  Inflammatory Glycoprotein 130 Signaling Links Changes in Microtubules and Junctophilin-2 to Altered Mitochondrial Metabolism and Right Ventricular Contractility.

Authors:  Sasha Z Prisco; Lynn M Hartweck; Lauren Rose; Patricia D A Lima; Thenappan Thenappan; Stephen L Archer; Kurt W Prins
Journal:  Circ Heart Fail       Date:  2021-12-20       Impact factor: 10.447

3.  Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension.

Authors:  Mattias Arvidsson; Abdulla Ahmed; Habib Bouzina; Göran Rådegran
Journal:  ESC Heart Fail       Date:  2021-01-05

4.  Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension.

Authors:  Sachindra R Joshi; Jun Liu; Troy Bloom; Elif Karaca Atabay; Tzu-Hsing Kuo; Michael Lee; Elitza Belcheva; Matthew Spaits; Rosa Grenha; Michelle C Maguire; Jeffrey L Frost; Kathryn Wang; Steven D Briscoe; Mark J Alexander; Brantley R Herrin; Roselyne Castonguay; R Scott Pearsall; Patrick Andre; Paul B Yu; Ravindra Kumar; Gang Li
Journal:  Sci Rep       Date:  2022-05-12       Impact factor: 4.996

5.  Development and Validation of a Nomogram for Predicting Obstructive Sleep Apnea in Patients with Pulmonary Arterial Hypertension.

Authors:  Meixi Hu; Anqi Duan; Zhihua Huang; Zhihui Zhao; Qing Zhao; Lu Yan; Yi Zhang; Xin Li; Qi Jin; Chenhong An; Qin Luo; Zhihong Liu
Journal:  Nat Sci Sleep       Date:  2022-08-09

Review 6.  Approaches to treat pulmonary arterial hypertension by targeting BMPR2: from cell membrane to nucleus.

Authors:  Benjamin J Dunmore; Rowena J Jones; Mark R Toshner; Paul D Upton; Nicholas W Morrell
Journal:  Cardiovasc Res       Date:  2021-09-28       Impact factor: 10.787
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.